Insider · CIK 0001296543

Ahn Mark J

Reports to the SEC for 4 companies · WORCESTER, MA

sec.gov

Transactions

Companies

Filings

CIK

0001296543

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-12-13	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2016-11-08	ABEOABEONA THERAPEUTICS INC.M Exercise/Conversion	Director	MExercise/Conversion	+150K sh	$2.31	+$347K	493,182
2016-11-08	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+150K sh	$2.31	+$347K	0
2016-02-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2015-07-31	ABEOABEONA THERAPEUTICS INC.P Purchase	Director	PPurchase	+18.2K sh	$5.50	+$100K	343,182
2015-05-11	ABEOABEONA THERAPEUTICS INC.A Award	Director	AAward	+300K sh	$7.34	+$2.2M	325,000
2015-05-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2015-05-11	ABEOABEONA THERAPEUTICS INC.A Award	Director	AAward	+300K sh	—	—	325,000
2015-05-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	Director	AAward	+100K sh	$7.34	+$734K	115,320
2015-01-26	ABEOABEONA THERAPEUTICS INC. · Common Stock Purchase WarrantsP Purchase	Director	PPurchase	+25K sh	$0.01	+$250	25,000
2015-01-26	ABEOABEONA THERAPEUTICS INC.P Purchase	Director	PPurchase	+25K sh	$4.00	+$100K	25,000
2014-06-30	SLSSELLAS Life Sciences Group, Inc.J Other	Director, President & CEO	JOther	+2,461 sh	$2.60	+$6,398.6	116,225
2014-06-30	SLSSELLAS Life Sciences Group, Inc.A Award	Director, President & CEO	AAward	+2,461 sh	$2.60	+$6,398.6	116,225
2014-01-27	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−325K sh	—	—	25,110
2014-01-27	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−122K sh	—	—	423,173
2014-01-27	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−200K sh	—	—	200,000
2014-01-27	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+50K sh	$2.31	+$116K	163,764
2014-01-27	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+100K sh	$1.38	+$138K	263,764
2014-01-27	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+325K sh	$1.38	+$448K	588,654
2014-01-27	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+200K sh	$0.72	+$144K	788,654
2014-01-27	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+122K sh	$1.71	+$208K	918,529
2014-01-27	SLSSELLAS Life Sciences Group, Inc.S Sale	Director, President & CEO	SSale	−797K sh	$4.83	−$3.85M	113,764
2014-01-27	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−50K sh	—	—	0
2014-01-27	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−100K sh	—	—	0
2013-12-31	SLSSELLAS Life Sciences Group, Inc.J Other	Director, President & CEO	JOther	+5,656 sh	$1.88	+$10.6K	113,764
2013-11-26	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+200K sh	—	—	200,000
2013-11-26	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+600K sh	—	—	600,000
2013-11-26	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+600K sh	—	—	600,000
2013-06-30	SLSSELLAS Life Sciences Group, Inc.J Other	Director, President & CEO	JOther	+7,862 sh	$1.35	+$10.6K	108,108
2013-01-29	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+650K sh	—	—	650,000
2012-12-31	SLSSELLAS Life Sciences Group, Inc.J Other	Director, President & CEO	JOther	+7,668 sh	$1.30	+$9,968.4	100,246
2012-07-10	SLSSELLAS Life Sciences Group, Inc.J Other	Director, President & CEO	JOther	+31.3K sh	$0.40	+$12.5K	92,578
2012-01-12	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+400K sh	—	—	400,000
2011-12-31	SLSSELLAS Life Sciences Group, Inc.J Other	Director, President & CEO	JOther	+31.3K sh	$0.40	+$12.5K	61,289
2011-12-07	SLSSELLAS Life Sciences Group, Inc.P Purchase	Director, President & CEO	PPurchase	+10K sh	$0.66	+$6,590	20,000
2011-04-20	SLSSELLAS Life Sciences Group, Inc.P Purchase	Director, President & CEO	PPurchase	+10K sh	$0.95	+$9,500	10,000
2011-03-31	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2011-03-31	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Director, President & CEO	AAward	+525K sh	—	—	525,000
2011-01-13	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Director, President & CEO	AAward	+50K sh	—	—	50,000
2010-05-26	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock option (right to buy)A Award	Director	AAward	+375K sh	—	—	750,000
2010-01-14	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Director, President & CEO	AAward	+50K sh	—	—	50,000
2009-01-15	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Director, President & CEO	AAward	+50K sh	—	—	150,000
2006-06-30	Talon Therapeutics, Inc.Stock Options (pursuant to anti-dilution provisions)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−79.7K sh	—	—	0
2006-06-30	Talon Therapeutics, Inc.Stock Options (pursuant to Section 16b-3)A Award	Director, President and CEO	AAward	+185K sh	—	—	184,555
2006-06-30	Talon Therapeutics, Inc.Stock Options (pursuant to anti-dilution provisions)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−185K sh	—	—	0
2006-06-30	Talon Therapeutics, Inc.Stock Options (pursuant to Section 16b-3)A Award	Director, President and CEO	AAward	+329K sh	—	—	329,016
2006-06-30	Talon Therapeutics, Inc.Stock OptionsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−329K sh	—	—	0
2006-06-30	Talon Therapeutics, Inc.A Award	Director, President and CEO	AAward	+74.9K sh	—	—	602,631
2006-06-30	Talon Therapeutics, Inc.Stock Options (pursuant to Section 16b-3)A Award	Director, President and CEO	AAward	+195K sh	—	—	194,568
2006-06-30	Talon Therapeutics, Inc.A Award	Director, President and CEO	AAward	+85K sh	—	—	287,774

Recent filings

Accepted (ET)
Dec 154
ABEONA THERAPEUTICS INC.0000318306-16-000052
SEC(opens sec.gov)
Nov 94
ABEONA THERAPEUTICS INC.0000318306-16-000048
SEC(opens sec.gov)
Feb 164
ABEONA THERAPEUTICS INC.0000318306-16-000041
SEC(opens sec.gov)
Aug 34
ABEONA THERAPEUTICS INC.0000318306-15-000039
SEC(opens sec.gov)
Jun 194/A
ABEONA THERAPEUTICS INC.0000318306-15-000034
SEC(opens sec.gov)
May 134
PLASMATECH BIOPHARMACEUTICALS INC0000318306-15-000024
SEC(opens sec.gov)
Jan 264
PLASMATECH BIOPHARMACEUTICALS INC0000318306-15-000002
SEC(opens sec.gov)
Sep 194/A
Galena Biopharma, Inc.0001250853-14-000119
SEC(opens sec.gov)
Jul 24
Galena Biopharma, Inc.0001390478-14-000029
SEC(opens sec.gov)
Jan 294
Galena Biopharma, Inc.0001250853-14-000035
SEC(opens sec.gov)

Companies

Address

C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET

WORCESTER, MA, 01605